CD163 and neoplasm: Wang et al. (2020) reported that metformin reprogrammed the TIME by increasing infiltrated CD8+ cytotoxic T lymphocyte, CD20+ B lymphocyte, tumor-suppressive (CD11+), and decreasing tumor-promoting (CD163+) macrophages.